Axsome Therapeutics, Inc. (AXSM) has a consensus analyst rating of Buy, based on 25 analysts covering the stock. Of those, 24 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for AXSM is $222.43, representing a +20.8% upside from the current price of $184.18. Price targets range from a low of $200.00 to a high of $260.00.
